NFE2L2 and lung carcinoma: On the other hand, BICR10 harbors an inactivating mutation on KEAP1 (R320Q) a negative regulator of NFE2L2. The R320Q mutation has been reported to stabilize NRF2 (encoded by NFE2L2) and enhances cell fitness as reported previously in lung cancer (Hast et al., 2014).